Mesoblast (MESO) Cash from Investing Activities (2016 - 2023)
Mesoblast (MESO) reported Cash from Investing Activities of $16000.0 for Q2 2023, up 134.04% on a YoY basis from $6836.4 in Q2 2022, and down 40.74% sequentially from $27000.0 in Q1 2023.
Mesoblast (MESO) Cash from Investing Activities (2016 - 2023) Analysis & Trends
Mesoblast (MESO) has 8 years of Cash from Investing Activities data on file, last reported at $16000.0 in Q2 2023.
- For the quarter ending Q2 2023, Cash from Investing Activities rose 134.04% year-over-year to $16000.0; the trailing twelve-month figure through Jun 2023 stood at -$194000.0 (up 16.38% YoY), and the FY2025 full-year result was $120000.0, up 223.71% from the prior year.
- Cash from Investing Activities retreated to $16000.0 in Q2 2023, from $27000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $27000.0 in Q1 2023 to a low of -$1.9 million in Q2 2020.
- A 5-year average of -$346333.3 and a median of -$151000.0 in 2021 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities plunged 670.0% in 2020 and soared 148.21% in 2023, its largest moves.
- Tracing MESO's Cash from Investing Activities over 5 years: stood at -$459000.0 in 2019, then grew by 11.33% to -$407000.0 in 2020, then soared by 92.63% to -$30000.0 in 2021, then decreased by 13.33% to -$34000.0 in 2022, then jumped by 147.06% to $16000.0 in 2023.
- Business Quant data shows MESO's Cash from Investing Activities at $16000.0 in Q2 2023, $27000.0 in Q1 2023, and -$34000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 172.62 Mn |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | -203,000.00 |
| Sep 30, 2022 | -203,000.00 |
| Jun 30, 2022 | -47,000.00 |
| Jun 30, 2022 | -47,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -30,000.00 |
| Dec 31, 2021 | -30,000.00 |
| Sep 30, 2021 | -99,000.00 |
| Sep 30, 2021 | -99,000.00 |
| Jun 30, 2021 | -223,000.00 |
| Jun 30, 2021 | -223,000.00 |
| Mar 31, 2021 | -936,000.00 |
| Mar 31, 2021 | -936,000.00 |